Back to Results
First PageMeta Content
Autoimmune diseases / Dermatomyositis / Juvenile dermatomyositis / Polymyositis / Inflammatory myopathy / Myopathy / Inclusion body myositis / Scleromyositis / Systemic lupus erythematosus / Health / Anatomy / Medicine


Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment
Add to Reading List

Document Date: 2012-04-18 14:55:36

Open Document

File Size: 184,54 KB

Share Result on Facebook

City

NA / /

Company

Wellcome Trust / Action Medical Research UK / Delphi / Environmental Autoimmunity Group / Clinical Studies Group / UK Myositis Support Group / Ó 2009 Elsevier Ltd. / /

Continent

North America / /

Country

United States / /

/

Event

Product Issues / /

Facility

University College London / Institute of Child Health / National Institute of Environmental Health Sciences / American College of Rheumatology / /

IndustryTerm

score tool / magnetic resonance imaging / validated tools / therapies for refractory disease / consensus protocols / organ systems / large collaborative research networks / recent international consensus working / large international collaborative / /

MarketIndex

Dermatomyositis Skin Severity / Myositis Damage / /

MedicalCondition

Anti-tumor necrosis / refractory disease / pulmonary involvement / treatment-refractory disease / overall disease / juvenile myositis / characteristic heliotrope rash / myopathy / herpes zoster / arthritis / Introduction Juvenile dermatomyositis / dysfunction / inclusion body myositis / muscle weakness / alopecia / severe unremitting disease / IIM idiopathic inflammatory myopathies / thigh muscle atrophy / intestinal perforation / injury / progressive multifocal leukoencephalopathy / less calcinosis / complex polygenic disorders / occult disease / Juvenile dermatomyositis / central nervous system disease / anti-tumour necrosis / illness / severe disease / JDM disease / infections / infectious agents / severe / refractory disease / idiopathic inflammatory myopathies / calcinosis / proximal muscle weakness / autoimmune diseases / Myositis specific autoantibodies / partial lipodystrophy / frequent insulin resistance / abdominal pain / systemic autoimmune disease / insulin resistance / extra-skeletal muscle disease / lipodystrophy / necrosis / immune dysfunction / disease / AST Global disease activity tool Extra-muscular disease / corticosteroid-dependent disease / upper respiratory infections / transient lymphopenia / untreated disease / dysphagia / idiopathic inflammatory myopathy / reduced cataract / chronic / adult disease / metabolic myopathies / therapy Juvenile dermatomyositis / inactive disease / cardiovascular disease / diabetes / fever / metabolic syndrome / skin disease / dysphonia / severe polymyositis / active disease / milder disease / Myositis / longer disease / diseases / osteoporosis / infection / contractures / rash / immunogenetics myositis / B-cell lymphoma / dermatomyositis / interstitial lung disease / symmetric proximal muscle weakness / rapidly progressing disease / /

MedicalTreatment

Adjunctive therapies / immunosuppressive therapies / invasive procedures / intravenous therapy / physical therapy / biological therapies / /

Organization

Paediatric Rheumatology International Trials Organisation / University College London / Rheumatology Unit / American College / National Institute of Environmental Health Sciences / Childhood Arthritis and Research Alliance / Department of Health and Human Services / Institute of Child Health / /

Person

Lisa G. Rider / Lucy R. Wedderburn / /

/

Position

Deputy Unit Chief / CHQ Physical Summary score Domain Physician / Consultant / Corresponding author / adult DM/PM / JDM Physician global assessment / /

Product

methylprednisolone / Cyclosporine / Cyclophosphamide / vitamin D / prednisolone / CAMPATH / prednisone / Azathioprine / responders / /

Technology

consensus protocols / alpha / antibodies / transplantation / human genome / MRI / magnetic resonance imaging / gene expression / genotype / CAT / /

URL

http /

SocialTag